Use of Biosensors in Clinical Trials: Barriers & Solutions to the Current Landscape

Dr Rhoda Au, MBA, PhD presented Cognitive Assessment in the Digital Era at the 2016 Digital Biomarkers Conference Hosted by the Coalition Against Major Disease (CAMD), an organization under the Critical Path Institute. 

The Coalition Against Major Diseases (CAMD) is a public-private partnership aimed at creating new tools and methods that can be applied to increase the efficiency of the development process of new treatments for Alzheimer’s disease (AD) and related neurodegenerative disorders with impaired cognition and function.

 

More Information about the conference and CAMD can be found at: https://c-path.org/programs/camd/